Table 3 Referrals for evaluation for obesity-related comorbidities, dietitian and endocrine counseling, prescriptions of anti-obesity medications and change in BMI-Z scores during a 1–2-year interval according to the presence of overweight or obesity and the recorded diagnosis of overweight or obesity.

From: Recorded diagnosis of overweight/obesity in primary care is linked to obesity care performance rates

 

Patients with overweight without a recorded diagnosis of overweight

Patients with overweight with a

Patients with obesity without a recorded diagnosis of obesity

Patients with obesity with a

P1

recorded diagnosis of overweight

recorded diagnosis of obesity

Age 2–5 years

 Total

9536 (34.2)

11,600 (41.7)

2158 (7.7)

4556 (16.4)

 

Sex

 males

5121 (53.7)a

5901 (50.9)b

1254 (58.1)c

2480 (54.4)d

<0.001

 females

4415 (46.3)

5699 (49.1)

904 (41.9)

2076 (45.6)

 

Blood pressure measurement

 males

456 (8.9)a

2011 (34.1)b

131 (10.4)a

1026 (41.4)c

<0.001

 females

332 (7.5)a

1934 (33.9)b

90 (10.0)c

821 (39.5)d

<0.001

P2

0.016

0.889

0.765

0.223

 

Referral to blood glucose measurement

 males

1632 (31.9)a

2915 (49.4)b

410 (32.7)a

1512 (61.0)c

<0.001

 females

1337 (30.3)a

3038 (53.3)b

310 (34.3)c

1318 (63.5)d

<0.001

 P2

0.1

<0.001

0.465

0.086

 

Referral to HbA1C measurement

 males

198 (3.9)a

1166 (19.8)b

65 (5.2)c

915 (36.9)d

<0.001

 females

198 (4.5)a

1503 (26.4)b

57 (6.3)c

883 (42.5)d

<0.001

 P2

0.145

<0.001

0.308

<0.001

 

Referral to liver enzyme measurement

 males

1828 (35.7)a

3144 (53.3)b

456 (36.4)a

1594 (64.3)c

<0.001

 females

1484 (33.6)a

3228 (56.6)b

332 (36.7)a

1367 (65.8)c

<0.001

 P2

0.035

<0.001

0.899

0.281

 

Referral to lipid profile measurement

 males

984 (19.2)a

2151 (36.5)b

261 (20.8)a

1318 (53.1)c

<0.001

 females

849 (19.2)a

2469 (43.3)b

229 (25.3)c

1179 (56.8)d

<0.001

 P2

0.895

<0.001

0.016

0.015

 

Referral to liver ultrasound

 males

165 (3.2)a

383 (6.5)b

45 (3.6)a

244 (9.8)c

<0.001

 females

174 (3.9)a

553 (9.7)b

40 (4.4)a

274 (13.2)c

<0.001

 P2

0.066

<0.001

0.383

<0.001

 

Referral to sleep study

 males

52 (1.0)a

90 (1.5)b

17 (1.4)ab

79 (3.2)c

<0.001

 females

34 (0.8)a

64 (1.1)a

6 (0.7)a

56 (2.7)b

<0.001

 P2

0.248

0.07

0.183

0.379

 

Referral to a dietitian

 males

132 (2.6)a

677 (11.5)b

50 (4.0)c

669 (27.0)d

<0.001

 females

140 (3.2)a

1063 (18.7)b

55 (6.1)c

759 (36.6)d

<0.001

 P2

0.094

<0.001

0.033

<0.001

 

Referral to an endocrinologist

 males

191 (3.7)a

350 (5.9)b

30 (2.4)c

282 (11.4)d

<0.001

 females

169 (3.8)a

516 (9.1)b

23 (2.5)c

336 (16.2)d

<0.001

 P2

0.844

<0.001

0.933

<0.001

 

Additional BMI documentation

 males

3429 (67.0)a

5081 (86.1)b

716 (57.1)c

2153 (86.8)d

<0.001

 females

2875 (65.1)a

4969 (87.2)b

497 (55.0)c

1759 (84.7)d

<0.001

 P2

0.061

0.091

0.35

0.049

 

1–2 years change in BMI-Z

 males

(n = 1478) −0.99 a (−1.66, −0.37)

(n = 2751) −0.38 b (−1.16, 0.38)

(n = 281) −1.59 c (-2.89, -0.56)

(n = 1161) −0.20 b (−1.02, 0.49)

<0.001

 females

(n = 1194) −0.97 a (−1.62, −0.32)

(n = 2727) −0.30 b (−0.89, 0.30)

(n = 217) −1.32 c (−2.36, −0.44)

(n = 975) −0.32 b (−0.99, 0.24)

<0.001

 P2

0.443

0.016

0.105

0.002

 

Age >5-18 years

 Total

112,604 (32.9)

117,102 (34.2)

20,829 (6.1)

92,244 (26.9)

 

Sex

 males

57,965 (51.5)a

57,534 (49.1)b

12,551 (60.3)c

51,832 (56.2)d

<0.001

 females

54,639 (48.5)

59,568 (50.9)

8278 (39.7)

40,412 (43.8)

 

Blood pressure measurement

 males

24,316 (41.9)a

36,748 (63.9)b

3552 (28.3)c

34,578 (66.7)d

<0.001

 females

22,054 (40.4)a

37,836 (63.5)b

2131 (25.7)c

26,882 (66.5)d

<0.001

P2

<0.001

0.209

<0.001

0.545

 

Referral to blood glucose measurement

 males

27,699 (47.8)a

37,300 (64.8)b

5140 (41.0)c

38,362 (73.9)d

<0.001

 females

31,316 (57.3)a

44,383 (74.5)b

3930 (47.5)c

32,799 (81.2)d

<0.001

 P2

<0.001

<0.001

<0.001

<0.001

 

Referral to HbA1C measurement

 males

7793 (13.4)a

19,536 (34.0)b

1471 (11.7)c

27,212 (52.5)d

<0.001

 females

9408 (17.2)a

25,041 (42.0)b

1233 (14.9)c

24,079 (59.6)d

<0.001

 P2

<0.001

<0.001

<0.001

<0.001

 

Referral to liver enzyme measurement

 males

29,342 (50.6)a

38,891 (67.6)b

5478 (43.6)c

3887 (75.0)d

<0.001

 females

32,748 (59.9)a

45,658 (76.6)b

4128 (49.9)c

33,133 (82.0)d

<0.001

 P2

<0.001

<0.001

<0.001

<0.001

 

Referral to lipid profile measurement

 males

22,931 (39.6)a

33,804 (58.8)b

4268 (34.0)c

36,625 (70.7)d

<0.001

 females

27,027 (49.5)a

41,132 (69.1)b

3382 (40.9)c

31,806 (78.7)d

<0.001

 P2

<0.001

<0.001

<0.001

<0.001

 

Referral to liver ultrasound

 males

2513 (4.3)a

4420 (7.7)b

411 (3.3)c

6545 (12.6)d

<0.001

 females

3633 (6.6)a

7060 (11.9)b

400 (4.8)c

7268 (18.0)d

<0.001

 P2

<0.001

<0.001

<0.001

<0.001

 

Referral to sleep study

 males

146 (0.3)a

283 (0.5)b

37 (0.3)a

404 (0.8)c

<0.001

 females

129 (0.2)a

212 (0.4)b

19 (0.2)ab

306 (0.8)c

<0.001

 P2

0.634

0.002

0.451

0.73

 

Referral to a dietitian

 males

2346 (4.0)a

6710 (11.7)b

900 (7.2)c

14,698 (28.4)d

<0.001

 females

4672 (8.6)a

12,596 (21.1)b

992 (12.0)c

16,360 (40.5)d

<0.001

 P2

<0.001

<0.001

<0.001

<0.001

 

Referral to an endocrinologist

 males

2530 (4.4)a

3795 (6.6)b

292 (2.3)c

4848 (9.4)d

<0.001

 females

3647 (6.7)a

5735 (9.6)b

273 (3.3)c

5641 (14.0)d

<0.001

 P2

<0.001

<0.001

<0.001

<0.001

 

Additional BMI documentation

 males

32,768 (56.5)a

45,602 (79.3)b

5098 (40.6)c

41,540 (80.1)d

<0.001

 females

30,977 (56.7)a

47,632 (80.0)b

3212 (38.8)c

32,906 (81.4)d

<0.001

 P2

0.585

0.003

0.009

<0.001

 

Prescription of metformin

 males

13 (0.0)a

90 (0.2)b

12 (0.1)b

472 (0.9)c

<0.001

 females

41 (0.1)a

214 (0.4)b

11 (0.1)a

711 (1.8)c

<0.001

 P2

<0.001

<0.001

0.426

<0.001

 

Prescription of orlistat

 males

2 (0.0)a

12 (0.0)b

0a

33 (0.1)c

<0.001

 females

5 (0.0)a

42 (0.1)b

0a

63 (0.2)c

<0.001

 P2

0.404

<0.001

 

<0.001

 

Prescription of GLP1 analogs

 males

3 (0.0)a

132 (0.2)b

3 (0.0)a

818 (1.6)c

<0.001

 females

14 (0.0)a

567 (1.0)b

2 (0.0)a

1427 (3.5)c

<0.001

 P2

0.011

<0.001

1

<0.001

 

1–2-year change in BMI-Z

 males

(n = 12,589) −0.30 a (−0.73, 0.08)

(n = 21,614) −0.04 b (−0.45, 0.34)

(n = 1781) −0.33 c (−0.89, 0.02)

(n = 19,933) −0.01 d (−0.42, 0.16)

<0.001

 females

(n = 11,830) -0.22 a (−0.58, 0.09)

(n = 22,413) −0.01 b (−0.35, 0.33)

(n = 1035) −0.30 c (−0.75, 0.02)

(n = 15,379) −0.06 d (−0.34, 0.17)

<0.001

 P2

<0.001

<0.001

0.083

<0.001

 
  1. The data are presented as n (%) or median (interquartile range, skewed distribution).
  2. The bold values in Table 3 was considered statistically significant for P1 < 0.005 and P2 < 0.001.
  3. P1 represents P values for the differences between the four comparison groups using the Pearson chi-square test or Fisher’s exact test for categorial variables or the Kruskal–Wallis 1-way ANOVA test for numerical variables with a skewed distribution. P1 < 0.005 was considered significant after the Bonferroni correction (11 distinct variables). Multiple comparison post-hoc analysis by the Bonferroni method was used to compare between each pair of groups. Rates with different superscripts (a, b, c, d) differ significantly from each other.
  4. P2 represents P values for the differences between males and females within each group using the Pearson chi-square test or Fisher’s exact test for categorial variables or the Mann–Whitney U-test for numerical variables with a skewed distribution. P2 < 0.001 was considered significant after the Bonferroni correction (11 distinct variables × 4 groups, 44 comparisons).